Home / Market News / $TFX

$TFX news and market catalysts

The 14 most recent market catalysts affecting $TFX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

14 catalysts 1 high impact 9 bullish 3 bearish Medical Devices
Nov 9, 2026 Corporate Catalyst Bullish Impact 55
Truist Securities Adjusts Price Target on Teleflex to $167 From $142
Truist Securities adjusted its price target for Teleflex Incorporated (TFX) upwards from $142 to $167. This indicates a more optimistic valuation of the company's future prospects …
Nov 6, 2026 Corporate Catalyst Bullish Impact 55
RBC Raises Price Target on Teleflex to $175 From $155
RBC Capital Markets has raised its price target for Teleflex (TFX) to $175 from $155, while reiterating its 'Outperform' rating. This upgrade indicates a more favorable outlook on …
Nov 5, 2026 Corporate Catalyst Neutral Impact 75
Teleflex Reports Third Quarter Financial Results and Full Year 2026 Outlook
Teleflex Incorporated announced its third-quarter 2026 financial results, showing a modest 0.2% revenue increase from continuing operations year-over-year, but a more robust 3.0% i…
Oct 22, 2026 Corporate Catalyst Bullish Impact 65
Teleflex Receives FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold
Teleflex announced that its Freesolve™ Resorbable Magnesium Scaffold received FDA Breakthrough Device Designation (BDD). This designation is significant because it is intended to e…
Sep 28, 2026 Corporate Catalyst Bullish Impact 75
Teleflex shares are trading higher after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $145 to $158.
This headline represents a significant corporate catalyst for Teleflex (TFX). An upgrade from 'Neutral' to 'Buy' by a major investment bank like B of A Securities, coupled with a r…
Sep 28, 2026 Corporate Catalyst Bullish Impact 55
B of A Securities Upgrades Teleflex to Buy, Raises Price Target to $158
B of A Securities analyst Craig Bijou upgraded Teleflex (TFX) from Neutral to Buy and raised the price target from $145 to $158. This analyst upgrade signals increased confidence i…
Aug 25, 2026 Corporate Catalyst Bullish Impact 55
Needham Maintains Buy on Teleflex, Raises Price Target to $170
Needham analyst Mike Matson maintained a 'Buy' rating on Teleflex (TFX) and raised the price target from $159 to $170. This action signals a continued positive outlook from a reput…
Aug 7, 2026 Corporate Catalyst Bullish Impact 55
Piper Sandler Reiterates Overweight on Teleflex, Raises Price Target to $169
This filing discloses that Piper Sandler analyst Jason Bednar has reaffirmed an 'Overweight' rating for Teleflex and raised the price target from $160 to $169. This is a positive s…
Aug 6, 2026 Corporate Catalyst Bearish Impact 75
Teleflex Lowers FY2026 GAAP EPS Guidance from $2.90-$3.20 to $2.54-$2.84 vs $2.96 Est
Teleflex (TFX) announced a significant reduction in its Fiscal Year 2026 GAAP EPS guidance, lowering the range from $2.90-$3.20 to $2.54-$2.84. This new forecast is notably below t…
Aug 6, 2026 Corporate Catalyst Bearish Impact 75
Teleflex Raises FY2026 Adj EPS Guidance from $6.25-$6.55 to $6.90-$7.20 vs $6.68 Est; Lowers FY2026 Sales Guidance from $2.280B-$2.300B to $2.260B-$2.280B vs $2.287B Est
Teleflex (TFX) has filed an 8-K to update its FY2026 financial guidance. The company raised its adjusted EPS guidance from $6.25-$6.55 to $6.90-$7.20, significantly exceeding the a…
Aug 6, 2026 Corporate Catalyst Bearish Impact 92
Teleflex Q2 Adj. EPS $1.76 Beats $1.28 Estimate, Sales $570.332M Beat $559.596M Estimate
Teleflex (TFX) announced Q2 earnings where both adjusted EPS and sales surpassed analyst expectations. This indicates a positive surprise for investors in the short term, as the co…
Jul 31, 2026 Corporate Catalyst Bullish Impact 55
Needham Maintains Buy on Teleflex, Raises Price Target to $159
Needham analyst Mike Matson maintained a 'Buy' rating on Teleflex (TFX) and raised the price target from $147 to $159. This action signals continued confidence in the company's per…
Jul 28, 2026 Corporate Catalyst Neutral Impact 55
UBS Initiates Coverage On Teleflex with Neutral Rating, Announces Price Target of $145
UBS analyst Patrick Wood initiated coverage on Teleflex (TFX) with a 'Neutral' rating and a $145 price target. This event is significant as new analyst coverage, especially from a …
Jul 21, 2026 Corporate Catalyst Bullish Impact 65
Teleflex Awarded National Premier Contract for Central Venous, Arterial and Intraosseous Access Devices
Teleflex (TFX) has been awarded a national group purchasing agreement with Premier, Inc., a major healthcare improvement company. This agreement, effective July 1, 2026, allows Pre…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.